Clinical Trial Update: Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Centanafadine SR for smoking cessation; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Centanafadine SR (Centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2025-06-13